Clinical Approach to Constipation
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of constipation
Constipation is one of the most common gastrointestinal complaints encountered in primary care, affecting approximately 16% of adults worldwide and up to 33% of adults over age 60. In the United States alone, constipation accounts for more than 2.5 million physician visits annually and results in over 700,000 emergency department visits per year. The economic burden is substantial, with direct healthcare costs exceeding $230 million annually, not including the significant indirect costs from lost productivity and reduced quality of life.
Definition
Constipation is a symptom-based disorder characterized by unsatisfactory defecation due to infrequent bowel movements, difficult stool passage, or both. The Rome IV criteria define functional constipation as the presence of at least two of the following for at least 3 months: straining during more than 25% of defecations, lumpy or hard stools in more than 25% of defecations, sensation of incomplete evacuation in more than 25% of defecations, sensation of anorectal obstruction in more than 25% of defecations, manual maneuvers to facilitate defecation in more than 25% of defecations, or fewer than three spontaneous bowel movements per week.
Key Epidemiological Facts
- Prevalence: 16% of adults globally; increases to 33% in those over 60 years
- Sex distribution: Women are 2-3 times more likely to report constipation than men
- Risk factors: Low fiber intake, sedentary lifestyle, polypharmacy, and low socioeconomic status
- Quality of life impact: Comparable to that of chronic conditions such as diabetes and depression
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 1 week | Dietary change, travel, new medication, acute illness, postoperative state | Usually self-limiting; investigate if associated with alarm features |
| Subacute | 1 week to 3 months | Medication effects, lifestyle changes, early organic disease, developing dyssynergia | Warrants investigation if no clear precipitant; may represent transition to chronicity |
| Chronic | Greater than 3 months | Functional constipation, slow-transit constipation, pelvic floor dysfunction, irritable bowel syndrome with constipation | Requires systematic evaluation; significant impact on quality of life |
Classification by Predominant Symptom
Infrequent Defecation
Definition: Fewer than three bowel movements per week
Typical causes: Slow-transit constipation, inadequate fiber and fluid intake, hypothyroidism, hypercalcemia
Clinical implication: Often responds to osmotic laxatives and prokinetic agents; may require transit studies
Difficult Defecation
Definition: Straining, incomplete evacuation, or need for manual maneuvers despite adequate stool frequency
Typical causes: Pelvic floor dyssynergia, rectocele, rectal prolapse, anal stenosis
Clinical implication: Laxatives often ineffective; may require anorectal manometry, defecography, and biofeedback therapy
Classification by Underlying Mechanism
| Type | Mechanism | Key Features | Treatment Approach |
|---|---|---|---|
| Normal-Transit Constipation | Perceived constipation with normal colonic transit; often related to hard stools or psychosocial factors | Most common type (approximately 60%); responds to fiber and lifestyle measures | Fiber supplementation, adequate hydration, reassurance |
| Slow-Transit Constipation | Reduced colonic motor activity; may involve abnormalities of interstitial cells of Cajal or enteric neurons | Infrequent urge to defecate; bloating; affects approximately 15-30% of chronic constipation | Prokinetics, stimulant laxatives, secretagogues; rarely colectomy |
| Defecatory Disorders (Outlet Obstruction) | Impaired rectal evacuation due to pelvic floor dyssynergia, anatomical abnormalities, or impaired rectal sensation | Straining, incomplete evacuation, digital facilitation; affects approximately 25-50% | Biofeedback therapy (first-line); surgery for structural causes |
Classification by Associated Features
| Pattern | Description | Suggests |
|---|---|---|
| Constipation with abdominal pain relieved by defecation | Cramping pain that improves after bowel movement; alternating with diarrhea possible | Irritable bowel syndrome with constipation |
| Constipation with bloating and early satiety | Upper gastrointestinal symptoms predominate; may have delayed gastric emptying | Gastroparesis, functional dyspepsia overlap, slow-transit constipation |
| Constipation with recent onset and weight loss | New symptom in patient over 50 years; associated anemia or blood in stool | Colorectal malignancy until proven otherwise |
| Constipation worse with specific medications | Temporal relationship with starting opioids, anticholinergics, or calcium channel blockers | Drug-induced constipation |
| Constipation since childhood | Lifelong symptoms; may have required laxatives since youth | Hirschsprung disease (if severe), congenital megacolon, or longstanding functional constipation |
Bristol Stool Form Scale
Clinical Utility: The Bristol Stool Form Scale is an essential tool for characterizing constipation objectively. It correlates with colonic transit time and helps standardize patient-physician communication.
| Type | Description | Clinical Interpretation |
|---|---|---|
| Type 1 | Separate hard lumps, like nuts | Severe constipation; very slow transit |
| Type 2 | Sausage-shaped but lumpy | Mild constipation |
| Type 3 | Sausage-shaped with cracks on surface | Normal |
| Type 4 | Smooth, soft sausage or snake | Normal; ideal stool form |
| Type 5 | Soft blobs with clear-cut edges | Lacking fiber; slightly loose |
| Type 6 | Fluffy pieces with ragged edges | Mild diarrhea |
| Type 7 | Watery, no solid pieces | Severe diarrhea |
Key Concept — The Three Pillars of Chronic Constipation: When evaluating chronic constipation, consider three fundamental questions: (1) Is colonic transit normal or slow? (2) Is there a defecatory disorder? (3) Is there an underlying secondary cause? Approximately 50% of patients with refractory constipation have overlapping slow transit and defecatory dysfunction, emphasizing the need for comprehensive evaluation.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of constipation
Normal defecation requires the coordinated function of the colon, rectum, pelvic floor muscles, and anal sphincters, all under the integrated control of the enteric nervous system, autonomic nervous system, and voluntary cortical input. Constipation can result from dysfunction at any level of this complex system, from impaired colonic motility to dyscoordination of the defecatory mechanism.
Normal Colonic and Defecatory Physiology
| Component | Structure | Function |
|---|---|---|
| Colonic Motility | Circular and longitudinal smooth muscle layers; myenteric plexus | Propels contents distally via segmental contractions and high-amplitude propagating contractions; absorbs water and electrolytes |
| Interstitial Cells of Cajal | Specialized pacemaker cells in colonic wall | Generate slow waves that coordinate smooth muscle contractions; reduced numbers linked to slow-transit constipation |
| Enteric Nervous System | Myenteric (Auerbach) and submucosal (Meissner) plexuses | Coordinates peristalsis; integrates sensory input; modulates secretion; dysfunction seen in colonic inertia |
| Rectum and Anal Canal | Internal anal sphincter (smooth muscle); external anal sphincter and puborectalis (striated muscle) | Provides continence at rest (internal sphincter); voluntary control of defecation (external sphincter) |
| Defecation Reflex | Rectal distension triggers afferent signals via pelvic nerves to sacral spinal cord | Initiates internal sphincter relaxation (rectoanal inhibitory reflex); coordinated with voluntary relaxation of external sphincter and puborectalis |
The Normal Defecation Sequence
Step-by-Step Process:
- Rectal filling: Stool enters the rectum, causing distension
- Sensory awareness: Rectal stretch receptors signal the urge to defecate
- Rectoanal inhibitory reflex: Internal anal sphincter relaxes reflexively
- Voluntary decision: Cortical centers decide whether to proceed or defer
- Assuming position: Squatting or sitting straightens the anorectal angle
- Valsalva maneuver: Increased intra-abdominal pressure
- Pelvic floor relaxation: Puborectalis and external sphincter relax, opening the anal canal
- Evacuation: Coordinated rectal contraction expels stool
Pathophysiological Mechanisms by Constipation Type
Normal-Transit Constipation
Mechanism
Colonic transit time is within normal limits, yet patients report constipation symptoms. This is often due to increased perception of symptoms, harder stool consistency from inadequate fiber or fluid, or psychological factors including anxiety and depression. It represents approximately 60% of patients with chronic constipation and generally responds well to conservative measures.
Slow-Transit Constipation (Colonic Inertia)
| Abnormality | Mechanism | Clinical Consequence |
|---|---|---|
| Reduced interstitial cells of Cajal | Loss of pacemaker activity leads to decreased colonic motor activity | Delayed transit throughout colon; infrequent bowel movements |
| Enteric neuropathy | Reduced neurons in myenteric plexus; decreased substance P and vasoactive intestinal peptide | Impaired coordination of peristalsis; poor response to stimulant laxatives |
| Smooth muscle abnormalities | Fibrosis or degeneration of colonic smooth muscle in severe cases | Refractory constipation; may require surgical intervention |
| Altered neurotransmitter signaling | Decreased serotonin (5-HT4) receptor activity; reduced nitric oxide | Basis for prokinetic therapy with 5-HT4 agonists |
Defecatory Disorders (Pelvic Floor Dyssynergia)
| Disorder | Mechanism | Clinical Features |
|---|---|---|
| Dyssynergic defecation | Paradoxical contraction or inadequate relaxation of puborectalis and external anal sphincter during attempted defecation | Excessive straining; incomplete evacuation; need for digital maneuvers; responds to biofeedback |
| Inadequate propulsive force | Weak rectal contraction or inability to generate adequate intra-abdominal pressure | Often seen in elderly or debilitated patients; may coexist with dyssynergia |
| Impaired rectal sensation | Elevated threshold for rectal distension perception; often from chronic rectal distension (megarectum) | Absence of urge to defecate; fecal impaction; overflow incontinence |
| Structural abnormalities | Rectocele, rectal prolapse, or intussusception impede normal evacuation | Vaginal splinting may help; may require surgical correction |
How Secondary Conditions Cause Constipation
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Hypothyroidism | Reduced metabolic rate slows colonic transit; decreased smooth muscle contractility | Constipation may resolve with thyroid hormone replacement |
| Diabetes mellitus | Autonomic neuropathy affects enteric nervous system; hyperglycemia impairs smooth muscle function | Optimize glycemic control; may need prokinetics |
| Hypercalcemia | Calcium inhibits smooth muscle contractility and neuronal excitability | Treat underlying cause; constipation improves with normalization of calcium |
| Parkinson disease | Loss of dopaminergic neurons affects enteric nervous system; alpha-synuclein deposits in gut | Constipation often precedes motor symptoms by years; requires multimodal approach |
| Multiple sclerosis | Demyelination disrupts neural pathways controlling defecation; pelvic floor dyssynergia common | Bowel program; biofeedback may help |
| Spinal cord injury | Loss of voluntary control; disrupted sacral reflex arc; colonic dysmotility | Level-dependent management; scheduled bowel care essential |
| Opioid use | Mu-opioid receptors in enteric nervous system inhibit peristalsis, increase fluid absorption, and raise sphincter tone | Peripheral mu-opioid receptor antagonists (methylnaltrexone, naloxegol) specifically target gut |
Mechanisms of Drug-Induced Constipation
Anticholinergic Mechanism
Drugs: Antihistamines, tricyclic antidepressants, antipsychotics, bladder antimuscarinics
Mechanism: Block muscarinic receptors in colonic smooth muscle, reducing contractility and transit
Clinical tip: Cumulative anticholinergic burden is key; review all medications
Opioid Mechanism
Drugs: All opioid analgesics; loperamide (peripheral action)
Mechanism: Activate enteric mu-opioid receptors causing reduced peristalsis, increased segmental contractions, enhanced water absorption
Clinical tip: Tolerance does not develop to constipating effects; prophylaxis essential
Calcium Channel Blocker Mechanism
Drugs: Verapamil (worst), diltiazem, nifedipine
Mechanism: Block L-type calcium channels in colonic smooth muscle, reducing contractile force
Clinical tip: Consider alternative antihypertensive if constipation problematic
Pathophysiology of Constipation Complications
| Complication | Mechanism | Clinical Significance |
|---|---|---|
| Fecal impaction | Prolonged stool retention leads to progressive water absorption, creating a hard mass that cannot be evacuated | May cause overflow incontinence, bowel obstruction, or stercoral ulceration; common in elderly and institutionalized |
| Hemorrhoids | Repeated straining increases venous pressure in hemorrhoidal plexus | Bleeding, prolapse, thrombosis; treating constipation is key to prevention |
| Anal fissure | Passage of large, hard stool tears anoderm; internal sphincter spasm perpetuates ischemia | Severe pain with defecation creates cycle of constipation avoidance |
| Rectal prolapse | Chronic straining weakens pelvic floor support structures | May worsen evacuation difficulty; often requires surgical repair |
| Stercoral ulcer and perforation | Pressure necrosis from impacted feces erodes colonic mucosa, potentially leading to perforation | Rare but life-threatening; high mortality; requires urgent surgical intervention |
Often Overlooked Mechanism: The Gut-Brain Axis
Constipation and psychological distress share bidirectional relationships mediated by the gut-brain axis. Anxiety and depression are significantly more prevalent in patients with chronic constipation, and psychological stress can alter colonic motility through hypothalamic-pituitary-adrenal axis activation and altered serotonergic signaling. Conversely, chronic constipation itself contributes to psychological distress through reduced quality of life and social embarrassment. This explains why some patients benefit from psychological interventions and why antidepressants (particularly selective serotonin reuptake inhibitors) may sometimes improve constipation symptoms.
3. History Taking
A comprehensive approach to eliciting the constipation history
Red Flags — Require Urgent Evaluation
- Rectal bleeding or melena — Colorectal malignancy, inflammatory bowel disease
- Unintentional weight loss (greater than 5% in 6 months) — Malignancy
- New onset after age 50 — Increased malignancy risk; warrants colonoscopy
- Iron deficiency anemia — Occult gastrointestinal blood loss
- Family history of colorectal cancer or inflammatory bowel disease — Hereditary risk
- Acute severe abdominal pain with distension — Bowel obstruction
- Fecal incontinence — Overflow from impaction, neurological disease
- Rapidly progressive symptoms — Obstructing lesion
Systematic History: The “MOVEMENTS” Approach
Use the mnemonic “MOVEMENTS” to ensure comprehensive history taking for constipation:
- M — Meaning to patient: What does the patient mean by “constipation”? Infrequent stools, hard stools, straining, incomplete evacuation?
- O — Onset and duration: When did symptoms begin? Acute, subacute, or chronic? Any precipitating event?
- V — Volume and consistency: Stool size and form (use Bristol Stool Scale); any mucus or blood?
- E — Evacuation difficulty: Straining? Sense of blockage? Need for digital maneuvers or splinting?
- M — Medications: Current medications, especially opioids, anticholinergics, calcium channel blockers, iron, antacids?
- E — Eating and lifestyle: Dietary fiber intake, fluid consumption, physical activity level, toilet habits?
- N — Neurological and systemic symptoms: Symptoms of hypothyroidism, diabetes, Parkinson disease, depression?
- T — Treatments tried: What laxatives or remedies have been used? Response to treatment?
- S — Social impact: Effect on quality of life, work, social activities? Psychological distress?
First Step: Define the Problem
What Does the Patient Mean by “Constipation”?
Patients use “constipation” to describe various symptoms. Always clarify which specific symptoms are present, as this guides diagnosis and treatment:
- Infrequent stools: Fewer than 3 bowel movements per week → suggests slow-transit constipation
- Hard or lumpy stools: Bristol types 1-2 → may respond to fiber and osmotic agents
- Excessive straining: May indicate defecatory disorder or hard stools
- Incomplete evacuation: Sensation of residual stool → suggests defecatory disorder or rectocele
- Sense of anorectal blockage: Feeling of obstruction → strongly suggests outlet dysfunction
- Need for digital maneuvers: Vaginal splinting or digital evacuation → defecatory disorder or rectocele
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Slow-transit constipation | Infrequent urge to defecate, bloating, symptoms since adolescence | “How often do you actually feel the urge to have a bowel movement?” |
| Pelvic floor dyssynergia | Excessive straining, incomplete evacuation, prolonged time on toilet | “Do you feel like stool is stuck and won’t come out even when you push?” |
| Rectocele | Need to press on vagina or perineum to evacuate, vaginal bulge | “Do you need to press on your vagina or the area between your legs to help pass stool?” |
| Irritable bowel syndrome with constipation | Abdominal pain relieved by defecation, bloating, variable stool form | “Do you have abdominal pain or cramping that gets better after you have a bowel movement?” |
| Opioid-induced constipation | Onset after starting opioids, hard stools, straining | “When did your constipation start in relation to when you began taking pain medications?” |
| Hypothyroidism | Fatigue, cold intolerance, weight gain, dry skin, constipation | “Have you noticed any fatigue, feeling cold, or unexplained weight gain along with the constipation?” |
| Colorectal malignancy | New onset in older adult, change in stool caliber, bleeding, weight loss | “Have you noticed your stools becoming narrower, or any blood in your stool or on the toilet paper?” |
| Parkinson disease | Tremor, bradykinesia, rigidity; constipation often precedes motor symptoms | “Have you or your family noticed any tremor, slowness of movement, or changes in your handwriting?” |
| Depression | Low mood, anhedonia, sleep disturbance, appetite changes | “How has your mood been lately? Have you lost interest in things you used to enjoy?” |
The Bowel Diary: An Essential Tool
Recommend a 2-Week Bowel Diary
A prospective bowel diary provides objective data and is more reliable than patient recall. Ask patients to record:
- Date and time of each bowel movement
- Stool consistency using Bristol Stool Scale (show patient the scale)
- Degree of straining (none, mild, moderate, severe)
- Sense of complete versus incomplete evacuation
- Use of laxatives or other aids
- Associated symptoms (pain, bloating, urgency)
Medication and Supplement History
Medications That Cause Constipation
- Opioid analgesics — Most common drug cause; no tolerance develops
- Anticholinergics — Antihistamines, tricyclics, antipsychotics, bladder medications
- Calcium channel blockers — Especially verapamil
- Iron supplements — Dose-dependent effect
- Calcium and aluminum antacids — Calcium carbonate, aluminum hydroxide
- Anticonvulsants — Carbamazepine, phenytoin
- Antiparkinsonian agents — Dopamine agonists, anticholinergics
- Diuretics — Through dehydration
- Clonidine — Central sympatholytic effect
- 5-HT3 antagonists — Ondansetron (commonly overlooked)
Laxative Use History
- Types used: Fiber, osmotic, stimulant, stool softeners, enemas, suppositories?
- Frequency: Daily, as needed, escalating use?
- Effectiveness: Which agents work? Which have failed?
- Duration: Short-term or long-term use?
- Doses: Are doses adequate? Many patients underdose
- Timing: Consistent timing? Adequate time allowed to work?
Supplements to Ask About
- Calcium supplements — Common constipating agent
- Iron supplements — Often not disclosed unless asked
Dietary and Lifestyle Assessment
| Factor | What to Assess | Target/Recommendation |
|---|---|---|
| Fiber intake | Fruits, vegetables, whole grains, legumes consumption | 25-30 grams per day (most adults consume only 12-15 grams) |
| Fluid intake | Total daily fluid consumption; caffeinated versus non-caffeinated | At least 1.5-2 liters per day; more if increasing fiber |
| Physical activity | Type, frequency, and duration of exercise | At least 150 minutes of moderate activity per week |
| Toilet habits | Ignoring urge to defecate? Privacy issues? Time constraints? | Respond to urge promptly; allow adequate unhurried time |
| Posture | Position used during defecation | Feet elevated (squatting position) straightens anorectal angle |
Relevant Medical and Surgical History
Medical Conditions
- Endocrine: Hypothyroidism, diabetes mellitus, hypercalcemia, pregnancy
- Neurological: Parkinson disease, multiple sclerosis, spinal cord injury, stroke
- Psychiatric: Depression, anxiety, eating disorders, history of abuse
- Connective tissue: Scleroderma, amyloidosis
- Gastrointestinal: Inflammatory bowel disease, diverticular disease, prior obstruction
Surgical History
- Abdominal surgery: Adhesions causing partial obstruction
- Pelvic surgery: Hysterectomy, rectal surgery affecting innervation
- Spinal surgery: May affect sacral nerve roots
- Anorectal surgery: Hemorrhoidectomy, fistula repair, sphincterotomy
- Obstetric history: Vaginal deliveries, tears, forceps use — risk factor for pelvic floor dysfunction
Family History
Key Family History Questions
- Colorectal cancer: First-degree relatives? Age at diagnosis? Hereditary syndromes (Lynch syndrome, familial adenomatous polyposis)?
- Inflammatory bowel disease: Crohn disease or ulcerative colitis in family members?
- Thyroid disease: Family history of hypothyroidism?
- Constipation: Other family members with chronic constipation? (suggests possible hereditary component or shared lifestyle factors)
4. Physical Examination
A systematic approach to examining patients with constipation
Systematic Framework: The physical examination in constipation serves two purposes: (1) identifying secondary causes and red flags, and (2) assessing for defecatory disorders. The digital rectal examination is the single most important component and should never be omitted.
General Inspection
- Nutritional status: Cachexia (malignancy), obesity (lifestyle factors, mobility limitations)
- Hydration: Dry mucous membranes, reduced skin turgor (dehydration contributing to constipation)
- Mobility: Gait disturbance, use of walking aids (reduced activity, neurological disease)
- Mental status: Affect, psychomotor retardation (depression), cognitive impairment (dementia affecting toileting)
- Parkinsonian features: Resting tremor, masked facies, bradykinesia, shuffling gait
- Thyroid status: Coarse features, dry skin, periorbital edema, delayed relaxation phase of reflexes
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Heart Rate | Bradycardia | Hypothyroidism; severe hypothyroidism can cause significant constipation |
| Blood Pressure | Orthostatic hypotension | Autonomic dysfunction (diabetes, Parkinson disease); dehydration |
| Temperature | Hypothermia | Severe hypothyroidism (myxedema) |
| Weight | Unintentional weight loss | Red flag for malignancy; document and trend |
| Body Mass Index | Obesity or underweight | Obesity associated with constipation; low BMI may suggest eating disorder or malignancy |
Thyroid Examination
- Inspection: Visible goiter, surgical scars
- Palpation: Thyroid size, nodules, consistency
- Associated signs: Coarse dry skin, periorbital edema, thinning of lateral eyebrows, delayed ankle reflex relaxation
Abdominal Examination
Inspection
- Distension: Generalized distension may indicate fecal loading or obstruction
- Visible peristalsis: Suggests mechanical obstruction
- Surgical scars: Previous surgery may cause adhesions
- Hernias: Incisional, umbilical, or groin hernias
Auscultation
- Normal bowel sounds: Does not exclude pathology
- High-pitched or tinkling: Mechanical obstruction
- Absent bowel sounds: Ileus, severe obstruction, peritonitis
Percussion
- Tympany: Gas-filled loops (obstruction, megacolon)
- Dullness: Fecal loading, mass, ascites
- Palpable stool: Firm masses in left lower quadrant or along colonic course
Palpation
- Fecal masses: Palpable stool in left lower quadrant or descending colon
- Abdominal masses: Concerning for malignancy; note location, size, mobility
- Tenderness: Localized tenderness may indicate complications; diffuse tenderness suggests impaction or obstruction
- Organomegaly: Hepatomegaly (metastatic disease), splenomegaly
- Hernias: Check inguinal and femoral regions
Digital Rectal Examination: The Essential Component
Critical Point
The digital rectal examination is the single most important part of the physical examination in constipation. It can identify defecatory disorders, fecal impaction, and anorectal pathology that would otherwise be missed. It should be performed in virtually all patients presenting with constipation.
Technique
- Explain the procedure and obtain consent
- Position patient in left lateral decubitus with knees drawn up
- Inspect the perianal area first
- Insert lubricated gloved finger gently through the anal canal
- Assess resting sphincter tone
- Ask patient to squeeze — assess voluntary squeeze pressure
- Ask patient to bear down as if having a bowel movement — assess for dyssynergia
- Palpate rectal contents, walls, and masses
- In women, palpate through posterior vaginal wall for rectocele
What to Assess and Document
| Component | Normal Finding | Abnormal Findings and Significance |
|---|---|---|
| Perianal inspection | Normal skin, no lesions | Fissures (anal fissure), external hemorrhoids, skin tags, fistula openings, patulous anus (neurological), dermatitis |
| Resting anal tone | Moderate resistance to insertion | Increased: anxiety, fissure, dyssynergia; Decreased: neurological disease, obstetric injury, prior surgery |
| Voluntary squeeze | Strong circumferential squeeze | Weak squeeze: pudendal neuropathy, obstetric injury, neurological disease |
| Push/bearing down maneuver | Relaxation of puborectalis and sphincter with perineal descent | Paradoxical contraction or no relaxation = dyssynergic defecation; absence of perineal descent = inadequate propulsion |
| Rectal contents | Empty or soft stool | Hard impacted stool, empty rectum despite urge (suggests rectal hyposensitivity), blood or mucus |
| Rectal masses | No masses palpable | Tumor (firm, fixed), polyp, internal hemorrhoids, rectal prolapse |
| Rectocele (in women) | No bulging of anterior rectal wall | Bulge of anterior wall during bearing down suggests rectocele |
| Prostate (in men) | Smooth, non-tender, normal size | Enlargement, nodules, tenderness (prostate pathology rarely causes constipation but should be assessed) |
Assessing for Dyssynergic Defecation at the Bedside
During the digital rectal examination, ask the patient to “bear down as if you are trying to have a bowel movement.” Normally, the puborectalis and external anal sphincter should relax, and you should feel your finger being pushed out with perineal descent. In dyssynergic defecation, you will feel paradoxical tightening of the sphincter/puborectalis or no relaxation at all. This simple bedside test has approximately 75% sensitivity for detecting dyssynergia when compared with anorectal manometry.
Focused Neurological Examination
| System | What to Assess | Significance |
|---|---|---|
| Motor examination | Tone, power, coordination | Parkinsonism (rigidity, bradykinesia); weakness (spinal cord lesion, myopathy) |
| Sensory examination | Perianal sensation (S2-S4), saddle area | Reduced: cauda equina syndrome, sacral nerve lesion |
| Reflexes | Anal wink (S2-S4), bulbocavernosus reflex, deep tendon reflexes | Absent anal wink: sacral nerve lesion; delayed ankle jerk relaxation: hypothyroidism |
| Gait | Observe walking, turning | Shuffling gait, reduced arm swing: Parkinson disease; spastic gait: spinal cord disease |
Signs of Systemic Disease
Hypothyroidism
- Coarse, dry skin
- Periorbital edema
- Thinning of lateral third of eyebrows
- Goiter
- Bradycardia
- Delayed relaxation of ankle reflexes
- Non-pitting edema
Parkinson Disease
- Resting tremor (pill-rolling)
- Cogwheel rigidity
- Bradykinesia
- Masked facies (hypomimia)
- Micrographia
- Stooped posture
- Shuffling gait with reduced arm swing
Expected Findings by Etiology
| Condition | General | Abdominal | Rectal Examination |
|---|---|---|---|
| Functional constipation (normal transit) | Usually normal | Often normal; may have mild distension | Normal or hard stool; normal tone and push |
| Slow-transit constipation | May have bloating; often young female | Distension; palpable stool throughout colon | May have empty rectum despite infrequent stools |
| Dyssynergic defecation | Usually normal | Often normal | Paradoxical sphincter contraction on push; no perineal descent |
| Fecal impaction | May appear uncomfortable; overflow incontinence possible | Distension; palpable fecal mass in left lower quadrant | Hard impacted stool filling rectum |
| Colorectal malignancy | Cachexia; pallor (anemia) | Mass may be palpable; hepatomegaly if metastatic | Mass may be palpable; blood on glove |
| Hypothyroidism | Myxedematous features; bradycardia | May have mild distension | Usually non-specific; delayed reflex relaxation |
| Parkinson disease | Tremor, rigidity, bradykinesia | Often normal | May have dyssynergia; impaired voluntary control |
Important Teaching Point
Normal examination is common! Many patients with chronic constipation, including those with slow-transit constipation, irritable bowel syndrome with constipation, or medication-induced constipation, will have completely normal physical examination findings. A normal examination does not exclude significant pathology or functional disorders. The history remains the most important component of evaluation, and specialized testing (anorectal manometry, colonic transit studies) may be needed to establish the diagnosis in refractory cases.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
The differential diagnosis of constipation is broad, encompassing primary (functional) disorders, secondary causes, and medication effects. A systematic approach based on clinical probability, patient age, and presence of alarm features guides efficient evaluation while ensuring serious conditions are not missed.
Fundamental Classification:
- Primary (functional) constipation: No identifiable structural or biochemical cause — includes normal-transit constipation, slow-transit constipation, defecatory disorders, and irritable bowel syndrome with constipation
- Secondary constipation: Attributable to an underlying condition (metabolic, neurological, structural) or medication
Primary causes account for approximately 90% of chronic constipation in the community. However, secondary causes must be excluded, particularly when alarm features are present.
Acute Constipation (Duration: Less than 1 week)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON | Dietary or lifestyle change | Recent travel, reduced fiber or fluid intake, decreased activity | None; self-limiting |
| COMMON | New medication | Temporal relationship with starting opioid, anticholinergic, or other constipating drug | None if cause identified |
| COMMON | Postoperative ileus | Recent surgery (especially abdominal); opioid use; immobility | Prolonged ileus, abdominal distension, vomiting |
| LESS COMMON | Fecal impaction | Elderly, immobile, or institutionalized; may present with overflow incontinence | Abdominal distension, confusion in elderly |
| LESS COMMON | Acute febrile illness | Dehydration, reduced oral intake, bed rest | Resolves with recovery |
| UNCOMMON BUT SERIOUS | Bowel obstruction | Absolute constipation (no flatus), colicky pain, vomiting, distension | Obstipation, bilious vomiting, high-pitched bowel sounds |
| UNCOMMON BUT SERIOUS | Volvulus (sigmoid or cecal) | Elderly; sudden onset; massive abdominal distension | Severe distension, peritoneal signs if ischemia |
| UNCOMMON BUT SERIOUS | Spinal cord compression | Back pain, leg weakness, urinary retention, saddle anesthesia | Neurological deficits; requires emergent imaging |
Chronic Constipation (Duration: Greater than 3 months)
Step-by-Step Approach to Chronic Constipation:
- Step 1: Exclude secondary causes — Is there an obvious medication cause? Are there symptoms suggesting metabolic, neurological, or structural disease?
- Step 2: Screen for alarm features — Age over 50 with new symptoms, rectal bleeding, weight loss, anemia, family history of colorectal cancer
- Step 3: Trial of empiric therapy — If no alarm features, trial fiber and osmotic laxatives for 4-8 weeks
- Step 4: Specialized testing if refractory — Anorectal manometry, balloon expulsion test, colonic transit study, defecography
Primary (Functional) Causes
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Normal-transit constipation (functional constipation) | 50-60% of chronic constipation | Normal transit time; often hard stools; responds to fiber and lifestyle measures; may have psychological component |
| COMMON | Irritable bowel syndrome with constipation | Approximately 35% overlap | Abdominal pain improved by defecation; bloating; meets Rome IV criteria for IBS; may alternate with diarrhea |
| LESS COMMON | Defecatory disorders (dyssynergic defecation, pelvic floor dysfunction) | 25-50% of refractory cases | Straining, incomplete evacuation, need for digital maneuvers; paradoxical contraction on examination; responds to biofeedback |
| LESS COMMON | Slow-transit constipation (colonic inertia) | 15-30% of refractory cases | Infrequent urge; bloating; often young women; poor response to fiber; delayed transit on scintigraphy or markers |
Secondary Causes
| Category | Condition | Key Features | Diagnostic Clue |
|---|---|---|---|
| Metabolic/Endocrine | Hypothyroidism | Fatigue, cold intolerance, weight gain, dry skin | Elevated TSH; constipation may be presenting symptom |
| Hypercalcemia | “Stones, bones, groans, moans” — renal stones, bone pain, constipation, confusion | Elevated serum calcium; check PTH if confirmed | |
| Diabetes mellitus | Autonomic neuropathy; often longstanding diabetes with other complications | Known diabetes; evidence of peripheral neuropathy | |
| Hypokalemia | Muscle weakness; may be caused by laxative abuse | Low serum potassium; check in patients with laxative overuse | |
| Neurological | Parkinson disease | Tremor, rigidity, bradykinesia; constipation often precedes motor symptoms by years | Motor examination findings; constipation may be earliest autonomic feature |
| Multiple sclerosis | Young adults; relapsing neurological symptoms; bladder dysfunction common | Other neurological symptoms; MRI findings | |
| Spinal cord lesion or injury | Depends on level; bowel and bladder dysfunction; sensory level | History of trauma or compression; neurological examination | |
| Autonomic neuropathy | Orthostatic hypotension, gastroparesis, erectile dysfunction | Often diabetic; multiple autonomic symptoms | |
| Hirschsprung disease (adult presentation) | Lifelong constipation; may present later with megacolon | Symptoms since birth; requires rectal biopsy for diagnosis | |
| Structural/Mechanical | Colorectal carcinoma | New onset in patient over 50; change in caliber; bleeding; weight loss | Colonoscopy required; iron deficiency anemia |
| Stricture (inflammatory, ischemic, anastomotic) | History of diverticulitis, inflammatory bowel disease, or prior surgery | Imaging or colonoscopy shows narrowing | |
| Rectocele | Women; vaginal bulge; need for vaginal splinting to defecate | Pelvic examination; defecography confirms | |
| Rectal prolapse or intussusception | Sensation of mass; incomplete evacuation; may see prolapse | Inspection; defecography | |
| Psychological | Depression | Low mood, anhedonia, sleep and appetite changes | Screen with PHQ-2 or PHQ-9 |
| Eating disorders (anorexia nervosa) | Severely restricted intake; low body weight; laxative abuse | Low BMI; distorted body image; often deny symptoms |
Anatomical Approach to Differential Diagnosis
Colonic Causes
Colorectal carcinoma
Stricture (diverticular, inflammatory, ischemic)
Slow-transit constipation
Megacolon (Hirschsprung, idiopathic)
Diverticular disease
Volvulus
Anorectal Causes
Dyssynergic defecation
Rectocele
Rectal prolapse/intussusception
Anal fissure
Anal stenosis
Hemorrhoids (severe)
Systemic/Metabolic Causes
Hypothyroidism
Hypercalcemia
Diabetes mellitus
Hypokalemia
Uremia
Lead poisoning
Pregnancy
Neurological Causes
Parkinson disease
Multiple sclerosis
Spinal cord injury/lesion
Autonomic neuropathy
Cerebrovascular disease
Cauda equina syndrome
Drug-Induced Constipation
| Drug or Drug Class | Mechanism | Characteristics | Management Approach |
|---|---|---|---|
| Opioid analgesics | Mu-receptor activation reduces peristalsis, increases fluid absorption, raises sphincter tone | Most common drug cause; affects 40-80% of chronic opioid users; no tolerance develops | Prophylactic laxatives; peripheral mu-opioid receptor antagonists (naloxegol, methylnaltrexone) |
| Anticholinergics | Block muscarinic receptors in gut smooth muscle | Cumulative effect from multiple agents; common in elderly (polypharmacy) | Review all medications; calculate anticholinergic burden; substitute where possible |
| Calcium channel blockers | Block L-type calcium channels in colonic smooth muscle | Verapamil worst (approximately 25%); diltiazem and dihydropyridines less so | Consider alternative antihypertensive if problematic |
| Iron supplements | Direct effect on gut mucosa; dose-dependent | Common; often underreported by patients | Reduce dose; try alternate formulation; give with stool softener |
| Calcium-containing antacids | Calcium inhibits smooth muscle contractility | Calcium carbonate; often used for osteoporosis or dyspepsia | Switch to alternative antacid; consider calcium citrate |
| Aluminum-containing antacids | Direct constipating effect; binite with phosphate | Less common now; may be in combination products | Use alternative antacid |
| Tricyclic antidepressants | Anticholinergic effect | Amitriptyline, nortriptyline commonly used for pain | Consider alternatives; may need laxative prophylaxis |
| Antipsychotics | Anticholinergic effect; dopamine blockade | Both typical and atypical; clozapine particularly problematic | Monitor bowel function; prophylactic laxatives especially with clozapine |
| Anticonvulsants | Various mechanisms; some have anticholinergic effects | Carbamazepine, phenytoin, gabapentin | Monitor; laxatives as needed |
| 5-HT3 antagonists | Block serotonin receptors in gut; reduce motility | Ondansetron commonly used; often overlooked cause | Use lowest effective dose; short courses when possible |
| Diuretics | Dehydration; hypokalemia | Especially loop diuretics at high doses | Ensure adequate hydration; monitor electrolytes |
| Antiparkinson agents | Anticholinergic effect (trihexyphenidyl, benztropine); dopamine effects | Constipation very common in Parkinson disease; drugs may worsen | Minimize anticholinergic agents; proactive bowel management |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| New constipation in patient over 50 with weight loss | Colorectal malignancy | Urgent colonoscopy |
| Constipation with fatigue, cold intolerance, weight gain | Hypothyroidism | Check TSH |
| Constipation with excessive straining but no urge to defecate | Slow-transit constipation | Colonic transit study |
| Straining with incomplete evacuation, need for digital maneuvers | Defecatory disorder (dyssynergia or rectocele) | Anorectal manometry, balloon expulsion test |
| Constipation with abdominal pain relieved by defecation | Irritable bowel syndrome with constipation | Rome IV criteria; trial of therapy |
| Constipation starting after new medication | Drug-induced constipation | Review medications; consider substitution |
| Constipation with tremor and slow movements | Parkinson disease | Neurological examination; neurology referral |
| Lifelong severe constipation since infancy | Hirschsprung disease | Rectal biopsy |
| Constipation with confusion, bone pain, polyuria | Hypercalcemia | Check serum calcium; if elevated, check PTH |
| Overflow incontinence in elderly patient | Fecal impaction | Digital rectal examination; disimpaction |
| Woman needing to press on vagina to defecate | Rectocele | Pelvic examination; defecography |
| Absolute constipation with distension and vomiting | Bowel obstruction | Urgent abdominal imaging (X-ray or CT) |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
The diagnosis of constipation is primarily clinical. Investigations serve to exclude secondary causes, identify alarm features, and characterize functional subtypes in refractory cases. A stepwise approach prevents unnecessary testing while ensuring serious conditions are not missed.
Key Principle: In patients without alarm features and with a clear history of functional constipation, empiric treatment should be initiated before extensive investigation. Reserve specialized testing for patients who fail initial therapy.
When to Investigate
| Clinical Scenario | Investigation Approach | Rationale |
|---|---|---|
| Young patient, no alarm features, clear functional history | Minimal or no testing; empiric therapy trial | Low pretest probability of organic disease; most respond to conservative measures |
| Any alarm feature present | Baseline bloods plus colonoscopy | Must exclude colorectal malignancy and inflammatory bowel disease |
| New onset after age 50 | Colonoscopy (if not up to date with screening) | Age-appropriate colorectal cancer screening |
| Refractory to empiric therapy (8-12 weeks) | Anorectal physiology testing; consider transit study | Characterize functional subtype to guide targeted therapy |
| Symptoms suggesting secondary cause | Targeted testing based on clinical suspicion | Treat underlying cause rather than symptom alone |
Baseline Investigations for Indicated Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Screen for anemia | Low hemoglobin; microcytic indices suggesting iron deficiency | Iron deficiency anemia is a red flag requiring colonoscopy |
| Thyroid-stimulating hormone (TSH) | Screen for hypothyroidism | Elevated TSH suggests hypothyroidism | Check in all patients with chronic constipation; easily treatable cause |
| Serum calcium | Screen for hypercalcemia | Elevated calcium; if confirmed, check PTH | Often overlooked; hyperparathyroidism is treatable |
| Fasting glucose or HbA1c | Screen for diabetes | Elevated glucose or HbA1c greater than 6.5% | Diabetic autonomic neuropathy causes constipation |
| Basic metabolic panel | Check electrolytes and renal function | Hypokalemia (may cause or result from laxative abuse); uremia | Potassium important if considering stimulant laxatives long-term |
Structural Investigations
Colonoscopy
Indications for Colonoscopy in Constipation
- Any alarm feature (rectal bleeding, weight loss, anemia, family history of colorectal cancer)
- New onset of constipation after age 50 (if not current with screening)
- Change in bowel habit not explained by clear precipitant
- Positive fecal occult blood test or fecal immunochemical test
- Refractory constipation to exclude structural cause before specialized testing
Note: Colonoscopy is not routinely indicated in young patients with typical functional constipation and no alarm features.
Abdominal Imaging
| Modality | Indications | What It Shows | Limitations |
|---|---|---|---|
| Plain abdominal radiograph | Suspected fecal loading; acute obstruction; assess stool burden | Fecal loading pattern; dilated loops if obstruction; megacolon | Poor specificity; does not replace clinical assessment |
| CT abdomen and pelvis | Suspected obstruction; mass lesion; complications | Transition point in obstruction; masses; volvulus; perforation | Radiation exposure; not first-line for uncomplicated constipation |
Specialized Physiological Testing
Reserve for patients with refractory constipation (failure of 8-12 weeks of appropriate therapy) to characterize the functional subtype and guide targeted treatment.
Anorectal Manometry
What It Measures
- Resting anal sphincter pressure
- Squeeze pressure (voluntary contraction)
- Rectoanal inhibitory reflex (RAIR)
- Simulated defecation dynamics
- Rectal sensation thresholds
Key Findings
- Dyssynergic defecation: Paradoxical increase in anal pressure or failure to relax during simulated defecation
- Absent RAIR: Suggests Hirschsprung disease (requires biopsy confirmation)
- Impaired rectal sensation: May indicate megarectum or neuropathy
- Weak squeeze: Pudendal neuropathy, obstetric injury
Balloon Expulsion Test
Simple and Valuable Screening Test
A water-filled balloon (50 mL) is placed in the rectum, and the patient attempts to expel it while seated on a commode. Normal expulsion occurs within 1-2 minutes. Inability to expel the balloon within 3 minutes suggests a defecatory disorder. This test has approximately 90% sensitivity for detecting dyssynergic defecation and can be performed in the office setting.
Colonic Transit Study
| Method | Procedure | Interpretation | Clinical Utility |
|---|---|---|---|
| Radiopaque marker study (Sitzmarks) | Patient swallows capsule with 24 markers; abdominal X-ray on day 5 | Normal: fewer than 5 markers remaining; Slow transit: greater than 5 markers scattered throughout colon; Outlet obstruction: markers concentrated in rectosigmoid | Widely available; inexpensive; distinguishes slow transit from outlet dysfunction |
| Wireless motility capsule (SmartPill) | Swallowed capsule measures pH, pressure, temperature throughout GI tract | Provides gastric, small bowel, and colonic transit times; colonic transit greater than 59 hours is abnormal | More detailed; identifies pan-GI dysmotility; higher cost |
| Scintigraphy | Radiolabeled meal; gamma camera imaging at intervals | Quantifies regional colonic transit | Research tool; limited availability |
Defecography (Evacuation Proctography)
Conventional Defecography
- Barium paste inserted into rectum
- Fluoroscopic imaging during rest and straining
- Evaluates anorectal angle, pelvic floor descent, evacuation
MR Defecography
- No radiation; better soft tissue visualization
- Identifies rectocele, intussusception, enterocele
- Preferred for anatomical assessment in women
- Limited availability; performed seated in open MRI ideally
Targeted Investigations by Suspected Etiology
If Suspecting Metabolic or Endocrine Cause
First-Line Tests
- TSH: Elevated in hypothyroidism; if abnormal, check free T4
- Serum calcium: Elevated in hyperparathyroidism, malignancy
- Fasting glucose/HbA1c: Screen for diabetes
- Potassium: Low in laxative abuse, diuretic use
Second-Line Tests
- PTH: If calcium elevated (primary hyperparathyroidism)
- Free T4: If TSH abnormal
- Celiac serology: If any suggestion of malabsorption
- Lead level: If occupational exposure suspected
If Suspecting Neurological Cause
Clinical Assessment
- Detailed neurological examination
- Assessment for Parkinson disease features
- Check for signs of spinal cord disease
- Evaluate for autonomic dysfunction
Investigations if Indicated
- MRI spine: If spinal cord lesion suspected
- MRI brain: For suspected multiple sclerosis or parkinsonism
- Autonomic function tests: Heart rate variability, tilt table
- Nerve conduction studies: If peripheral neuropathy suspected
If Suspecting Hirschsprung Disease
Diagnosis Requires Rectal Biopsy
Adult Hirschsprung disease is rare but should be considered in patients with lifelong severe constipation since infancy. Anorectal manometry showing absent rectoanal inhibitory reflex (RAIR) is suggestive but not diagnostic. Full-thickness rectal biopsy demonstrating absence of ganglion cells in the myenteric plexus is required for definitive diagnosis.
Empiric Treatment Trials as Diagnostic Tools
Sequential Empiric Therapy Approach
In patients without alarm features, response to empiric therapy can support the diagnosis and guide further management:
- Trial 1 — Fiber supplementation: 25-30 g/day for 4-6 weeks — good response suggests normal-transit constipation or inadequate dietary fiber
- Trial 2 — Osmotic laxative: Polyethylene glycol 17 g daily for 4-6 weeks — good response supports functional constipation
- Trial 3 — Add stimulant laxative: If osmotic alone insufficient — failure suggests possible defecatory disorder or slow-transit constipation requiring specialized testing
Important: Failure of empiric therapy should prompt anorectal physiology testing before escalating to newer agents, as defecatory disorders are common and require biofeedback, not more laxatives.
Investigation Algorithm Summary
Stepwise Approach:
- All patients: Thorough history and physical examination including digital rectal examination
- If alarm features: CBC, metabolic panel, TSH, calcium → colonoscopy
- If no alarm features: Consider baseline labs (TSH, calcium) → empiric therapy trial
- If refractory (8-12 weeks): Anorectal manometry + balloon expulsion test
- If anorectal testing normal: Colonic transit study
- If anatomical abnormality suspected: Defecography (MR preferred)
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Absolute constipation (no stool or flatus) with abdominal distension, vomiting | EMERGENT | NPO, IV fluids, nasogastric tube if vomiting, urgent surgical consultation, CT abdomen |
| Severe abdominal pain with peritoneal signs | EMERGENT | Suspect perforation (stercoral ulcer) or ischemia; urgent surgical evaluation |
| New neurological symptoms (leg weakness, urinary retention, saddle anesthesia) | EMERGENT | Suspect cauda equina syndrome; urgent MRI spine; neurosurgical consultation |
| Fecal impaction with overflow incontinence or confusion | URGENT | Digital disimpaction; enemas; monitor for complications; investigate underlying cause |
| New constipation with alarm features (bleeding, weight loss, anemia) | URGENT | Expedited colonoscopy within 2 weeks; baseline bloods |
| Severe constipation in patient on clozapine | URGENT | High risk of ileus and bowel ischemia; aggressive laxative regimen; consider admission if severe |
| Chronic constipation without alarm features | ROUTINE | Outpatient evaluation; lifestyle modifications; empiric laxative therapy |
| Constipation refractory to empiric therapy | ROUTINE | Refer for specialized testing (anorectal manometry, transit study) |
Step 2: Classify by Duration and Context
Acute (Less than 1 week)
Key questions:
- New medication started?
- Recent surgery or illness?
- Travel or dietary change?
- Signs of obstruction?
Proceed to Algorithm A
Subacute (1 week to 3 months)
Key questions:
- Identifiable precipitant?
- Progressive worsening?
- Associated symptoms?
- Response to laxatives?
Proceed to Algorithm B
Chronic (Greater than 3 months)
Key questions:
- Infrequent stools or difficult defecation?
- Alarm features present?
- Response to prior therapy?
- Impact on quality of life?
Proceed to Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Constipation
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Recent opioid initiation | Opioid-induced constipation | Start prophylactic laxative (stimulant plus stool softener); consider peripheral mu-opioid receptor antagonist if refractory |
| Postoperative state (especially abdominal surgery) | Postoperative ileus | Ambulation, minimize opioids, gum chewing; usually resolves in 3-5 days; if prolonged, investigate for mechanical cause |
| Travel or dietary change | Situational constipation | Increase fluids and fiber; short-term osmotic laxative; usually self-limiting |
| Absolute constipation with distension and vomiting | Bowel obstruction | NPO, IV fluids, nasogastric decompression, urgent imaging and surgical consultation |
| Elderly or immobile patient with fecal mass on examination | Fecal impaction | Manual disimpaction, enemas, then establish bowel regimen to prevent recurrence |
| Febrile illness with dehydration | Illness-related constipation | Rehydration; will resolve with recovery; short-term laxative if needed |
Algorithm B: Subacute Constipation
| Clinical Scenario | Likely Diagnosis | Action |
|---|---|---|
| Clear medication cause identified | Drug-induced constipation | Discontinue or substitute offending agent if possible; add laxative if drug essential |
| Symptoms of hypothyroidism present | Secondary to hypothyroidism | Check TSH; treat with levothyroxine if confirmed; constipation typically improves |
| Age over 50, change in bowel habit, no clear precipitant | Possible colorectal pathology | Colonoscopy to exclude malignancy or structural cause |
| No alarm features, responds to fiber and laxatives | Functional constipation developing | Continue conservative measures; reassess if symptoms persist beyond 3 months |
| Progressive symptoms despite laxatives | Possible slow-transit or defecatory disorder | Digital rectal examination to assess for dyssynergia; consider early referral if not improving |
Algorithm C: Chronic Constipation
| Clinical Scenario | Likely Subtype | Action |
|---|---|---|
| Responds to fiber and osmotic laxatives; normal examination | Normal-transit constipation | Continue fiber 25-30 g/day, adequate fluids, osmotic laxative as needed; reassurance |
| Abdominal pain relieved by defecation; bloating; meets Rome IV criteria | Irritable bowel syndrome with constipation | Low FODMAP diet trial; antispasmodics; consider linaclotide or plecanatide (dual effect on pain and constipation) |
| Excessive straining; incomplete evacuation; paradoxical contraction on examination | Dyssynergic defecation | Confirm with anorectal manometry and balloon expulsion test; biofeedback therapy is first-line treatment |
| Infrequent urge to defecate; bloating; poor response to fiber and osmotic laxatives | Slow-transit constipation | Confirm with colonic transit study; stimulant laxatives, prokinetics (prucalopride), secretagogues; rarely consider colectomy |
| Need to splint vagina to defecate; bulge on examination | Rectocele | Confirm with defecography; pelvic floor physical therapy first; surgical repair if significant and symptomatic |
| Refractory to multiple therapies; mixed features | Overlapping disorders (slow transit plus dyssynergia in 50%) | Complete physiological evaluation; treat dyssynergia first (biofeedback); then address slow transit |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient has not had a bowel movement in 7 days | Assess for obstruction (examination, X-ray if concerned); if no obstruction, give osmotic laxative or enema | Establish regular bowel regimen; investigate cause of severe constipation |
| Fiber makes symptoms worse (bloating, discomfort) | Reduce fiber; trial osmotic laxative instead | Consider slow-transit constipation or irritable bowel syndrome; fiber often poorly tolerated in these conditions |
| Patient requires daily stimulant laxatives | Ensure adequate fiber and osmotic therapy first; daily stimulants are acceptable if needed | Reassess for defecatory disorder; stimulant dependence is largely a myth; long-term use is safe |
| Patient reports laxatives “don’t work” | Verify adequate dosing and timing; ensure compliance | If truly refractory, suspect defecatory disorder; refer for anorectal manometry |
| Chronic opioid user with refractory constipation despite laxatives | Optimize conventional laxatives first; add peripheral mu-opioid receptor antagonist (naloxegol, methylnaltrexone) | Consider opioid rotation; assess if opioid truly needed; lubiprostone also approved for opioid-induced constipation |
| Patient uses digital maneuvers to defecate | This strongly suggests defecatory disorder or structural abnormality | Refer for anorectal manometry, balloon expulsion test, and defecography |
| Elderly nursing home patient found with fecal incontinence | Check for fecal impaction (digital rectal examination); this is usually overflow incontinence | Disimpact; establish prophylactic bowel regimen; scheduled toileting |
| Patient wants to avoid all medications | Focus on lifestyle: fiber 25-30 g/day, fluids 2 L/day, regular exercise, respond to urge, toilet positioning (squat) | If still symptomatic, explain osmotic laxatives like polyethylene glycol are safe for long-term use |
| Constipation causing anal fissure | Treat fissure (topical diltiazem or nitroglycerin, sitz baths); stool softeners essential | Aggressively treat constipation to prevent recurrence; fiber and osmotic laxatives |
| Pregnant patient with constipation | Fiber first; then osmotic laxatives (polyethylene glycol, lactulose) — both safe in pregnancy | Avoid stimulant laxatives in first trimester if possible; reassure this is very common in pregnancy |
Treatment Escalation Pathway
Stepwise Treatment Approach for Chronic Constipation:
- Step 1 — Lifestyle and fiber: Dietary fiber 25-30 g/day; adequate fluids; exercise; toilet positioning; respond to urge (4-6 weeks trial)
- Step 2 — Osmotic laxative: Polyethylene glycol 17 g daily (first-line) or lactulose; titrate to effect (4-6 weeks trial)
- Step 3 — Add or switch to stimulant: Bisacodyl or senna; can be used regularly despite traditional concerns (4-6 weeks trial)
- Step 4 — Specialized testing: Anorectal manometry, balloon expulsion test before further escalation
- Step 5 — Targeted therapy based on subtype:
- Dyssynergia → Biofeedback therapy (70% success rate)
- Slow transit → Prucalopride (prokinetic) or secretagogues (linaclotide, plecanatide, lubiprostone)
- Irritable bowel syndrome with constipation → Linaclotide or plecanatide (address pain and constipation)
- Step 6 — Refractory cases: Combination therapy; consider colectomy only for proven slow-transit constipation with failed medical therapy and excluded defecatory disorder
Troubleshooting Refractory Constipation
Ask These Questions Before Labeling as Refractory
- Was the diagnosis correct? Have secondary causes been excluded?
- Was fiber adequate? Many patients take insufficient fiber (need 25-30 g/day)
- Was laxative dosing adequate? Underdosing is common; polyethylene glycol can be titrated up
- Was duration adequate? Need at least 4-6 weeks at therapeutic dose
- Was compliance good? Many patients take laxatives inconsistently
- Has defecatory disorder been excluded? This is present in 25-50% of refractory cases and requires biofeedback, not more laxatives
- Are there overlapping conditions? 50% have both slow transit and dyssynergia
- Are psychological factors contributing? Depression, anxiety, and history of abuse affect treatment response
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Define what the patient means by constipation: Always clarify whether the patient is experiencing infrequent stools, hard stools, straining, or incomplete evacuation — these suggest different underlying mechanisms and require different treatments.
The digital rectal examination is essential: It can identify fecal impaction, assess sphincter tone, detect dyssynergia with the bearing-down maneuver, and identify rectal masses — never skip it in a constipation evaluation.
Defecatory disorders are common and underdiagnosed: Present in 25-50% of patients with refractory constipation; they do not respond to laxatives and require biofeedback therapy. Always consider this diagnosis when laxatives fail.
Stimulant laxatives are safe for long-term use: The traditional belief that stimulant laxatives cause “lazy bowel” or dependency is not supported by evidence. They can be used safely on a regular basis when needed.
Opioid tolerance does not develop to constipation: Unlike analgesia, tolerance to the constipating effects of opioids does not develop. Patients on chronic opioids need ongoing laxative prophylaxis indefinitely.
Biofeedback is highly effective for dyssynergia: Success rates of approximately 70% make biofeedback the first-line treatment for pelvic floor dyssynergia — far better than any medication for this condition.
Check TSH and calcium in all patients with chronic constipation: Hypothyroidism and hypercalcemia are easily treatable causes that should not be missed. These simple blood tests should be part of the baseline workup.
Constipation often precedes Parkinson disease motor symptoms: Constipation may appear 10-20 years before tremor and other motor features. A new movement disorder in a patient with longstanding constipation should raise suspicion.
Critical Pitfalls to Avoid
Skipping the digital rectal examination: This is the most important part of the physical examination in constipation. Without it, fecal impaction, dyssynergia, and rectal masses may be missed.
Escalating laxatives without testing for defecatory disorder: If standard laxatives fail after 8-12 weeks, obtain anorectal manometry and balloon expulsion test before adding newer, expensive agents. Dyssynergia requires biofeedback, not more laxatives.
Attributing all constipation to “not enough fiber”: While fiber helps many patients, it can worsen symptoms in slow-transit constipation and irritable bowel syndrome with constipation by increasing bloating without improving transit.
Missing fecal impaction presenting as overflow incontinence: In elderly patients, new-onset fecal incontinence is often overflow around an impacted mass, not true incontinence. Always perform a digital rectal examination.
Ignoring alarm features in older patients: New constipation after age 50, especially with weight loss, bleeding, or anemia, requires colonoscopy to exclude colorectal cancer before attributing symptoms to functional constipation.
Forgetting medication review: Drug-induced constipation is extremely common. Always review the medication list, including over-the-counter medications and supplements (calcium, iron, antacids).
Recommending colectomy without excluding dyssynergia: Surgery for slow-transit constipation has poor outcomes if coexisting dyssynergia is not addressed first. Always exclude pelvic floor dysfunction before considering surgery.
Underestimating clozapine-induced constipation: Constipation on clozapine can progress to life-threatening ileus and bowel ischemia. These patients require aggressive prophylactic laxative regimens and close monitoring.
Key Takeaways
- Constipation is a symptom, not a diagnosis — always clarify the specific complaints (infrequency, straining, incomplete evacuation) as these guide management
- Primary (functional) constipation accounts for approximately 90% of chronic cases, but secondary causes must be excluded, especially with alarm features
- The three main subtypes of functional constipation are normal-transit (60%), slow-transit (15-30%), and defecatory disorders (25-50%) — and they often overlap
- Digital rectal examination is essential and can diagnose fecal impaction, assess for dyssynergia, and detect masses
- Red flags requiring urgent evaluation include: new onset after age 50, rectal bleeding, weight loss, anemia, family history of colorectal cancer, and acute obstruction
- Baseline investigations should include complete blood count, TSH, and serum calcium in most patients with chronic constipation
- Colonoscopy is indicated for alarm features or new symptoms after age 50 but is not routinely needed for typical functional constipation in young patients
- Empiric therapy with fiber and osmotic laxatives should be tried for 8-12 weeks before specialized testing in patients without alarm features
- Anorectal manometry and balloon expulsion test are essential before labeling constipation as “refractory” — dyssynergia is present in 25-50% of treatment failures
- Biofeedback therapy has approximately 70% success rate for dyssynergic defecation and should be first-line treatment for this condition
- Drug-induced constipation is extremely common — opioids, anticholinergics, and calcium channel blockers are the most frequent culprits
- Long-term stimulant laxative use is safe — the “lazy bowel” myth is not supported by evidence
Quick Reference Algorithm
Systematic Approach to Constipation:
- Clarify the complaint: What does the patient mean by “constipation”? Infrequency, straining, incomplete evacuation, or hard stools?
- Assess for alarm features: Age over 50 with new symptoms, rectal bleeding, weight loss, anemia, family history of colorectal cancer, acute obstruction symptoms
- Perform digital rectal examination: Assess for impaction, sphincter tone, dyssynergia (bearing-down test), masses, and rectocele
- Review medications: Identify and address drug-induced causes (opioids, anticholinergics, calcium channel blockers, iron, calcium supplements)
- Check baseline investigations: Complete blood count, TSH, serum calcium; colonoscopy if alarm features or age-appropriate screening due
- Initiate empiric therapy: Lifestyle measures, fiber 25-30 g/day, osmotic laxative (polyethylene glycol); trial for 8-12 weeks
- If refractory: Obtain anorectal manometry and balloon expulsion test to exclude defecatory disorder before escalating therapy
- Target treatment to subtype: Dyssynergia → biofeedback; slow transit → prokinetics or secretagogues; irritable bowel syndrome with constipation → linaclotide or plecanatide